Vibecotamab (XmAb14045) is a potent bispecific antibody that targets CD123 and CD3, promoting T cell-mediated elimination of CD123-expressing cells. It exhibits antitumor properties and is used in studies on acute myeloid leukemia [1].
CAS Number:
[2138442-13-2]
Target:
Integrin
* VAT and and shipping costs not included. Errors and price changes excepted